ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 374 filers reported holding ENCOMPASS HEALTH CORP in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427 | -3.0% | 6,356 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $440 | +25.7% | 6,504 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $350 | -29.3% | 6,473 | -21.8% | 0.00% | -33.3% |
| Q4 2022 | $495 | -99.8% | 8,279 | +66.9% | 0.00% | +200.0% |
| Q3 2022 | $224,000 | -11.8% | 4,960 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $254,000 | -20.1% | 4,537 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $318,000 | +55.1% | 4,477 | +39.7% | 0.00% | -50.0% |
| Q1 2020 | $205,000 | -18.3% | 3,204 | -11.5% | 0.00% | 0.0% |
| Q4 2019 | $251,000 | -52.9% | 3,621 | -58.0% | 0.00% | -66.7% |
| Q4 2018 | $533,000 | +51.4% | 8,631 | +90.9% | 0.01% | +100.0% |
| Q3 2018 | $352,000 | +16.9% | 4,521 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $301,000 | +22.9% | 4,445 | +3.6% | 0.00% | 0.0% |
| Q1 2018 | $245,000 | – | 4,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
| Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
| BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
| Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
| Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
| REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
| Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
| Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
| HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
| Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |